OpGen

Ares Genetics, Belgian Infectious Disease Center Partner on Computational Dx Tools

In Brief This Week: Thermo Fisher Scientific, FDA, Fulgent Genetics, OpGen, More

OpGen Enters At-Market Agreement to Sell up to $10.7M in Stock

Curetis, Leader Life Sciences Partner to Distribute Unyvero in UAE and Qatar

In Brief This Week: Labcorp, Lucid Diagnostics, Seegene, Babson Diagnostics, Danaher, More

In Brief This Week: Qiagen, Renalytix, OpGen, PerkinElmer, Avacta, Paige, More

OpGen Q4 Revenues Flat on Modest Product Sale Gains

CareDx, Castle Bio, Lucira Health, Others Announce Preliminary Q4, FY21 Earnings Results

In Brief This Week: Roche, Veracyte, Hologic, Danaher, Chembio Diagnostics, Natera, and More

OpGen Q3 Revenues Climb 9 Percent

Roche, Thermo Fisher Scientific, DiaSorin, BioMérieux, and Others Obtain FDA Clearances in September

OpGen Receives FDA Clearance for AMR Panel, Prelim Q3 Revenues Up 9 Percent

OpGen Q2 Revenues Fall 32 Percent

In Brief This Week: OpGen, Yale School of Public Health, ProPhase Labs, Core Diagnostics, and More

OpGen Q1 Revenues Rise 34 Percent on Combination With Curetis

In Brief This Week: Unilabs, PerkinElmer, Invitae, Becton Dickinson, and More

OpGen Fourth Quarter Revenues Increase 64 Percent

In Brief This Week: Quest Diagnostics, LabCorp, PerkinElmer, Thermo Fisher Scientific, and More